Rheumatology
News
FDA announces approval of fifth adalimumab biosimilar, Abrilada
Pfizer said that current plans are to launch the drug in the United States in 2023.
Conference Coverage
CVD risk in black SLE patients 18 times higher than in whites
ATLANTA – “This study [identifies] a population that needs more attention, more targeted CVD prevention,” presenter Dr. Shivani Garg said.
News
AAD-NPF Pediatric psoriasis guideline advises on physical and mental care
Topics in this guideline for pediatric psoriasis include systemic and topical treatments, management of comorbidities, and quality of life.
Latest News
Severe hypoglycemia, poor glycemic control fuels fracture risk in older diabetic patients
The association between severe hypoglycemia, poor glycemic control, and fracture risk seems to be stronger in men than in postmenopausal women.
Conference Coverage
Consider centralized pain in patients with rheumatic disease
LAS VEGAS – Every patient with chronic pain should complete a fibromyalgia survey, Dr. Daniel J. Clauw says.
Conference Coverage
Osteoporosis remains a costly burden to older U.S. adults
ORLANDO – Older women and minorities continue to bear the brunt of the burden of fragility fractures in the United States.
FDA/CDC
FDA approves nintedanib for scleroderma interstitial lung disease
Interstitial lung disease affects half of scleroderma patients in the United States, and until now there was no treatment.
Latest News
CDC, SAMHSA commit $1.8 billion to combat opioid crisis
Some of the funds will be used to help improve overdose monitoring.
News
Cannabidiol may interact with rheumatologic drugs
CBD is known to inhibit the cytochrome P450 enzymes that metabolize corticosteroids and other medications.
News
High-dose vitamin D for bone health may do more harm than good
A randomized trial showed an inverse dose-response relationship between high-dose vitamin D supplementation and bone quality in healthy adults.